Qritive is a leading developer in artificial intelligence (AI)-powered digital pathology for cancer diagnosis, and Corista, a leading provider of clinical, research and educational digital pathology image management solutions, are entering into a new partnership to integrate their digital pathology tools.
The partnership will see Qritive’s AI modules integrated with Corista’s DP3 image management platform. Corista’s DP3 systems, enables voice collaborations, remote case review, global consults, integrated image analysis, and a proprietary laboratory information system connector. Combined with Qritive’s modules for prostate, colon, lymph metastasis, and the quantification of IHC markers, the integrated solution will allow for computational modules to scan for prostate and colon cancers, quantify IHC markers, and detect lymph node metastasis.
The solution will allow for pathologists to increase efficiencies in workflow, through prioritization and grading of specific cases. These increased efficiencies will enable pathologists to focus more time on complex cases, improving cancer detection and diagnosis.
Click here to read the original news story.